To further explore whether the loss of SETD2 exacerbates the progression of SMAD4‐deficient CRC, we generated CRC cell line SW620 with SMAD4 and SETD2 co‐mutation and observed cell proliferation. Here, SETD2 is linked to colorectal carcinoma.